Disseminated intravascular coagulation: cause, molecular mechanism, diagnosis, and therapy

Fangchen Gong1, Xiangtao Zheng1, Shanzhi Zhao1

  • 1Department of Emergency Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China.

Medcomm
|January 17, 2025
PubMed

Insights

Disseminated intravascular coagulation (DIC) is a severe condition causing blood clots and bleeding. This review covers its causes, diagnosis, and treatment, highlighting the need for better management strategies.

Area of Science:

  • Hematology
  • Pathophysiology
  • Critical Care Medicine

Background:

  • Disseminated intravascular coagulation (DIC) is a life-threatening condition involving systemic coagulation activation.
  • It paradoxically leads to both thrombosis and hemorrhage due to clotting factor depletion.
  • DIC is triggered by various critical illnesses like sepsis, trauma, and malignancy.

Purpose of the Study:

  • To provide a comprehensive overview of Disseminated Intravascular Coagulation (DIC).
  • To emphasize the clinical significance and challenges in managing DIC.
  • To highlight recent advances and future research directions for improved patient outcomes.

Main Methods:

  • This review synthesizes current knowledge on DIC pathophysiology, causes, and clinical presentation.
  • It examines established and emerging diagnostic criteria and laboratory assessments.
  • Treatment strategies, including supportive care and targeted therapies, are discussed.

Main Results:

  • DIC involves excessive thrombin generation, platelet activation, and fibrinogen consumption.
  • Diagnosis remains challenging, relying on clinical context and laboratory findings.
  • Current treatments focus on managing underlying conditions and supportive measures.

Conclusions:

  • Effective management of DIC requires early recognition and prompt treatment of underlying causes.
  • Further research is crucial for enhancing diagnostic accuracy and therapeutic efficacy.
  • Improved strategies are needed to reduce morbidity and mortality associated with DIC.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
606
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
693
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.4K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.1K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.3K